MORGAN STANLEY

Position in REPL — Replimune Group, Inc.

CIK 895421 NEW YORK, NY

Back to REPL Full portfolio

Position in REPL

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,943,525

-$2,977,183 QoQ

Shares Held

646,213

-20.7% QoQ

Ownership

0.770%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 94% Shared 0% None 6%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. REPL ranks #175 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	43,571,633	$2,090,131,227
2	ROIV	Roivant Sciences Ltd.	51,828,325	$1,435,644,595
3	VRTX	Vertex Pharmaceuticals Inc / Ma	3,188,881	$1,423,962,911
4	REGN	Regeneron Pharmaceuticals, Inc.	1,319,329	$1,019,366,352
5	TECH	BIO-TECHNE Corp	8,532,873	$445,927,935
6	MRNA	Moderna, Inc.	8,471,263	$430,340,154
7	ARGX	Argenx SE	560,711	$409,459,203
8	APLS	Apellis Pharmaceuticals, Inc.	10,042,399	$404,005,708

All Filings in REPL

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,943,525	646,213	-20.7%	Shares	Defined	2026-05-15
2025-12-31	$7,920,708	814,888	-40.8%	Shares	Defined	2026-05-27
2025-09-30	$5,763,421	1,375,519	+49.2%	Shares	Defined	2026-05-27
2025-06-30	$8,562,199	921,658	-0.7%	Shares	Defined	2025-08-15
2025-03-31	$9,050,553	928,262	-11.4%	Shares	Defined	2025-05-15
2024-12-31	$12,686,759	1,047,627	-38.0%	Shares	Defined	2025-05-15
2024-09-30	$18,520,237	1,689,803	-2.6%	Shares	Defined	2025-05-14
2024-06-30	$15,620,886	1,735,654	-34.6%	Shares	Defined	2025-05-14
2024-03-31	$21,683,454	2,654,034	-40.3%	Shares	Defined	2024-10-17
2023-12-31	$37,490,127	4,447,228	+847.5%	Shares	Defined	2024-08-16
2023-09-30	$8,030,729	469,359	-28.2%	Shares	Defined	2023-11-15
2023-06-30	$15,175,775	653,565	-23.1%	Shares	Defined	2023-08-14
2023-03-31	$15,001,265	849,449	+38.3%	Shares	Defined	2023-05-15
2022-12-31	$16,705,039	614,156	+10.0%	Shares	Defined	2023-02-14
2022-09-30	$9,644,082	558,430	-7.8%	Shares	Defined	2022-11-14
2022-06-30	$10,589,711	605,819	+3.2%	Shares	Defined	2022-10-27
2022-03-31	$9,964,658	586,847	+66.9%	Shares	Defined	2022-10-27
2021-12-31	$9,528,927	351,621	-1.9%	Shares	Defined	2022-02-14
2021-09-30	$10,623,832	358,429	-9.3%	Shares	Defined	2021-11-15
2021-06-30	$15,182,313	395,167	+17.7%	Shares	Defined	2021-08-23
2021-03-31	$10,246,597	335,844	-10.1%	Shares	Defined	2021-05-17
2020-12-31	$14,247,727	373,466	+9787.9%	Shares	Defined	2021-02-16
2020-09-30	$86,946	3,777	-90.9%	Shares	Defined	2020-11-13
2020-06-30	$1,032,591	41,553	+1188.1%	Shares	Defined	2020-08-14
2020-03-31	$32,162	3,226	—	Shares	Defined	2020-05-26
No filing history on record for this holder in this stock.